Cryptococcus (Greek for "hidden sphere") is a genus of fungi, which grow in culture as yeasts. The sexual forms or teleomorphs of Cryptococcus species are filamentous fungi in the genus Filobasidiella. The name Cryptococcus is used when referring to the yeast states of the fungi.
The cells of these species are covered in a thin layer of glycoprotein capsular material that has a gelatin-like consistency, and that among other functions, serves to help extract nutrients from the soil. However, the C. neoformans capsule is different, in being richer in glucuronic acid and mannose, having O-acetyl groups, and functioning as the major virulence factor in cryptococcal infection and disease.
About 37 species of Cryptococcus are recognized, but the taxonomy of the group is currently being re-evaluated with up-to-date methods. The majority of species live in the soil and are not harmful to humans. Very common species include C. laurentii and C. albidus. Of all species, C. neoformans is the major human and animal pathogen. However, C. laurentii and C. albidus have been known to occasionally cause moderate-to-severe disease, to be specific meningitis, in human patients with compromised immunity (owing to HIV infection, cancer chemotherapy, metabolic immunosuppression, etc.).
C, neoformans is the most prominent medically important species. It is best known for causing a severe form of meningitis and meningoencephalitis in people with HIV/AIDS. It may also infect organ-transplant recipients and people receiving certain cancer treatments. C. neoformans is found in the droppings of wild birds, often pigeons; when dust of the droppings is stirred up, it can infect humans or pets that inhale the dust. Infected humans and animals do not transmit their infection to others; they are not infectious. When plated on Niger or birdseed agar, C. neoformans produces melanin, which causes the colonies to have a brown color, and this melanin production is believed to be an important virulence factor.
C. gattii (formerly C. neoformans var gattii) is endemic to tropical parts of the continent of Africa and Australia. It is capable of causing disease (cryptococcosis) in nonimmunocompromised people. It has been isolated from eucalyptus trees in Australia. Since 1999, an outbreak of C. gattii infections has occurred in eastern Vancouver Island, an area not generally thought to be endemic for this organism. Cases have since been described in the Pacific Northwest, in both Canada and the United States.
The taxonomy of this species has been reviewed; it has been proposed that it be divided into five species - C. gattii, C. bacillisporus, 'C. deuterogattii, C. tetragattii, and C. decagattii.
C. albidus has been isolated from the air, dry moss in Portugal, grasshoppers in Portugal, and tubercular lungs. The colonies on a macroscopic level are cream-color to pale pink, with the majority of colonies being smooth with a mucoid appearance. Some of the colonies have been found to be rough and wrinkled, but this is a rare occurrence. This species is very similar to C. neoformans, but can be differentiated because it is phenol oxidase-negative, and, when grown on Niger or birdseed agar, C. neoformans produces melanin, causing the cells to take on a brown color, while the C. albidus cells stay cream-colored. On a microscopic level, C. albidus has an ovoid shape, and when viewed with India ink, a capsule is apparent. This species also reproduces through budding. The formation of pseudohyphae has not been seen. C. albidus is able to use glucose, citric acid, maltose, sucrose, trehalose, salicin, cellobiose, and inositol, as well as many other compounds, as sole carbon sources. This species is also able to use potassium nitrate as a nitrogen source. C. albidus produces urease, as is common for Cryptococcus species. C. albidus is very easily mistaken for other Cryptococcus species, as well as species from other genera of yeast, so should be allowed to grow for a minimum of 7 days before attempting to identify this species.
While this species is most frequently found in water and plants and is also found on animal and human skin, it is not a frequent human pathogen. Cases of C. albidus infection have increased in humans during the past few years, and it has caused ocular and systemic disease in those with immunoincompetent systems, for example, patients with AIDS, leukemia, or lymphoma. While systemic infections have been found with increasing regularity in humans, it is still relatively rare in animals. The administration of amphotericin B in animals has been successful, but in humans, the treatment usually has poor results.
C. albidus var. albidus is a variety of C. albidus that has been considered unique. It differs from C. neoformans because of its ability to assimilate lactose, but not galactose. This species is also considered unique because its strains have a maximum temperature range from between 25 and 37°C. This is important because it violates van Uden’s rule, which states that the yeast strains of a particular species cannot have their maximum growth temperature vary by more than 5°C. However, some debate exists as to whether or not this maximum temperature range for the strains of C. albidus is accurate, because other research has shown that C. albidus var. albidus strains cannot grow at 37°C. Another variety, 'C. albidus var. diffluens is different from C. neoformans in that it can assimilate melibiose ,but not galactose.
C. uniguttulatus (Filobasidium uniguttulatus is a teleomorph) was the first non-neoformans Cryptococcus to infect a human. It was isolated from ventricular fluid from a patient having had a neurosurgical procedure. This species was found to be very sensitive to amphotericin B at the minimum inhibitory dose. This species was first isolated from a human nail.
- Cryptococcus adeliensis
- Cryptococcus aerius
- Cryptococcus albidosimilis
- Cryptococcus antarcticus
- Cryptococcus aquaticus
- Cryptococcus ater
- Cryptococcus bhutanensis
- Cryptococcus consortionis
- Cryptococcus curvatus
- Cryptococcus phenolicus
- Cryptococcus skinneri
- Cryptococcus terreus
- Cryptococcus vishniacci
Data related to Cryptococcus (Tremellaceae) at Wikispecies
- Ross A, Taylor IE (1981) Extracellular glycoprotein from virulent and avirulent Cryptococcus species. Infection and Immunity. 31(3):911–8
- Casadevall A and Perfect JR (1998) Cryptococcus neoformans. American Society for Microbiolgy, ASM Press, Washington DC, 1st edition.
- Cheng MF, Chiou CC, Liu YC, Wang HZ, Hsieh KS (2001) Cryptococcus laurentii fungemia in a premature neonate. Journal of Clinical Microbiology. 39(4):1608–11. A good review of C. laurentii cases till year 2000.
- USA (2016-11-15). "(("cryptococcus"[MeSH Terms] OR ("cryptococcosis"[TIAB] NOT Medline[SB - PubMed - NCBI". Ncbi.nlm.nih.gov. Retrieved 2016-12-18.
- "What is Cryptococcus infection (cryptococcosis)?". Center for Disease Control and Prevention. April 28, 2010. Retrieved 8 March 2012.
- Labrecque O., Sylvestre D. and Messier S. (2005) Systemic Cryptococcus albidus infection in a Doberman Pinscher. J Vet Diagn Invest 17:598-600
- Sugita T, Cho O, Takashima M (2017) Current status of taxonomy of pathogenic yeasts. Med Mycol J 58(3):J77-J81
- Lindberg J, Hagen F, Laursen A, et al. (2007). "Cryptococcus gattii Risk for Tourists Visiting Vancouver Island, Canada". Emerg Infect Dis. 13 (1): 178–79. doi:10.3201/eid1301.060945. PMC . PMID 17370544.
- MacDougall L, Kidd SE, Galanis E, et al. (2007). "Spread of Cryptococcus gattii in British Columbia, Canada, and Detection in the Pacific Northwest, USA". Emerg Infect Dis. 13 (1): 42–50. doi:10.3201/eid1301.060827. PMC . PMID 17370514.
- Fonseca A., Scorzeti G., and Fell J. (2000) Diversity in the yeast Cryptococcus albidus and related species as revealed by ribosomal DNA sequence analysis. Can. J. Microbiol. 46:7-27
- (2006) 0609-1 Cryptococcus albidus. Cmpt Mycol Plus
- Vishniac H. S., Kurtzman C. P. (1992) Cryptococcus anarcticus sp. nov. and Cryptococcus albidosimilis sp. nov., Basidioblasomycetes from Antarctic Soils. Int. J. Syst. Bacteriol. 42(4) 547-553